Interview 6/6

top of page

Join the Waiting List >>

NEWS

Startup entrepreneurs who succeed are fast, focused and passionate

Startup entrepreneurs who succeed are fast, focused and passionate

Startup entrepreneurs who succeed are fast, focused and passionate

Interview with Véronique Stephan, >>venture>> mentor and Chief Commercial Officer at Corplex. Véronique Stephan encourages startup...

Nov 13, 20201 min read

Business cases that solve real problems are key

Business cases that solve real problems are key

Business cases that solve real problems are key

Interview with Claudia Zimmermann, >>venture>>mentor & juror, and Founder of C-Advisor. Claudia Zimmermann offers guidance on creating...

Nov 13, 20202 min read

Beyond technology: investors are interested in financial models and strong teams

Beyond technology: investors are interested in financial models and strong teams

Beyond technology: investors are interested in financial models and strong teams

Interview with Rhea Hamilton, Managing Director Ventures at OGCI Climate Investments. Rhea Hamilton explains what startup investors look...

Nov 13, 20202 min read

Got a great business idea but not sure where to start?🚀

Join us at the Starting Line and get practical answers to the six key questions every entrepreneur should ask — from building your team to finding the right funding.

📍 Lausanne — October 5, 2026 | 6:30 PM
EPFL, MED Building
🎟️ Register for Lausanne [Link in bio]

📍 Zurich — October 20, 2026 | 6:30 PM
ETH Zurich, CHN Building (Grüner Boden)
🎟️ Register for Zurich [Link in bio]

Come with your idea. Leave with a clearer path forward — and one step closer to CHF 150,000 in prizes.

Ready to venture forward?

Got a great business idea but not sure where to start?🚀

Join us at the Starting Line and get practical answers to the six key questions every entrepreneur should ask — from building your team to finding the right funding.

📍 Lausanne — October 5, 2026 | 6:30 PM
EPFL, MED Building
🎟️ Register for Lausanne [Link in bio]

📍 Zurich — October 20, 2026 | 6:30 PM
ETH Zurich, CHN Building (Grüner Boden)
🎟️ Register for Zurich [Link in bio]

Come with your idea. Leave with a clearer path forward — and one step closer to CHF 150,000 in prizes.

Ready to venture forward?

🚀 Ready to start your >>venture>> 2027 application?

Join us at The Starting Line at EPFL and get first-hand advice from some of the very people who will be evaluating your application. 👀

You’ll get the chance to:
🤔 Ask our jurors what makes an application stand out
🎯 Get practical tips on how to approach the six evaluation criteria
🖼️ Learn how to frame your answers and present your startup at its best
❓ Get your questions answered before submitting your application

📍 EPFL (MED Building)
📅 October 5 (in exactly one week!)
🎟️ Free event — but registration is required [Link in bio]

Let's get you started right away — don't wait any longer! Our application deadline is November 30, 2026.

🚀 Ready to start your >>venture>> 2027 application?

Join us at The Starting Line at EPFL and get first-hand advice from some of the very people who will be evaluating your application. 👀

You’ll get the chance to:
🤔 Ask our jurors what makes an application stand out
🎯 Get practical tips on how to approach the six evaluation criteria
🖼️ Learn how to frame your answers and present your startup at its best
❓ Get your questions answered before submitting your application

📍 EPFL (MED Building)
📅 October 5 (in exactly one week!)
🎟️ Free event — but registration is required [Link in bio]

Let's get you started right away — don't wait any longer! Our application deadline is November 30, 2026.

🏁 Ready to take your first step towards >>venture>> 2027?

This year, we’re putting you at the Starting Line.

Join us in Lausanne or Zurich for an evening designed to help you understand what makes a strong >>venture>> application — and start working on yours.

🔎 Watch the jury in action as real jurors score startups live and unpack the six criteria they’ll be looking for.

✍️ Get writing in the Writing Room, where practical prompts will help you structure your thinking around one of the six jury criteria.

💡 Get challenged in our Clinics, where experienced mentors will give you feedback and answer your questions.

🤝 Meet the community over an apéro with fellow founders, the >>venture>> team, and members of our expert network.

Whether you have a startup, a side project, or just an idea, come find out what it takes to get to the Top 200.

📅 Lausanne — October 5, 2026 | 6:30 PM
📍 EPFL, MED Building
🎟️ Register by following the link in our bio

📅 Zurich — October 20, 2026 | 6:30 PM
📍 ETH Zurich, CHN Building (Grüner Boden)
🎟️ Register with the link in our bio

Your 2027 journey starts here.

🏁 Ready to take your first step towards >>venture>> 2027?

This year, we’re putting you at the Starting Line.

Join us in Lausanne or Zurich for an evening designed to help you understand what makes a strong >>venture>> application — and start working on yours.

🔎 Watch the jury in action as real jurors score startups live and unpack the six criteria they’ll be looking for.

✍️ Get writing in the Writing Room, where practical prompts will help you structure your thinking around one of the six jury criteria.

💡 Get challenged in our Clinics, where experienced mentors will give you feedback and answer your questions.

🤝 Meet the community over an apéro with fellow founders, the >>venture>> team, and members of our expert network.

Whether you have a startup, a side project, or just an idea, come find out what it takes to get to the Top 200.

📅 Lausanne — October 5, 2026 | 6:30 PM
📍 EPFL, MED Building
🎟️ Register by following the link in our bio

📅 Zurich — October 20, 2026 | 6:30 PM
📍 ETH Zurich, CHN Building (Grüner Boden)
🎟️ Register with the link in our bio

Your 2027 journey starts here.

🚀 Introducing The Starting Line!

Applications for the 2027 >>venture>> competition open on October 1 — and this year, we’re kicking things off differently.

On October 5, join us at EPFL to discover what it takes to make it to the Top 200 and get a first taste of the new >>venture>> experience.

Watch real jurors score startups live, discover the six criteria they’ll be looking for, and put your own thinking to the test.

✍️ Writing Room: work on your own answer to one of the six jury criteria, with practical prompts and guidance to help you structure your thinking.
💡 Clinics: get your answer challenged by experienced mentors, and ask questions before submitting your application.
🤝 Apéro: meet fellow founders, the >>venture>> team, and members of our expert community.

Whether you have a startup, a side project, or just an idea, The Starting Line is for you.

And with the 2027 edition marking 30 years of >>venture>>, there’s never been a better time to join us.

🔗 Find out more about the event and register by following the link in our bio.

📅 October 5, 2026 | 6:30 PM
📍 EPFL, MED Building (Lausanne)
🎟️ Free to attend

🚀 Introducing The Starting Line!

Applications for the 2027 >>venture>> competition open on October 1 — and this year, we’re kicking things off differently.

On October 5, join us at EPFL to discover what it takes to make it to the Top 200 and get a first taste of the new >>venture>> experience.

Watch real jurors score startups live, discover the six criteria they’ll be looking for, and put your own thinking to the test.

✍️ Writing Room: work on your own answer to one of the six jury criteria, with practical prompts and guidance to help you structure your thinking.
💡 Clinics: get your answer challenged by experienced mentors, and ask questions before submitting your application.
🤝 Apéro: meet fellow founders, the >>venture>> team, and members of our expert community.

Whether you have a startup, a side project, or just an idea, The Starting Line is for you.

And with the 2027 edition marking 30 years of >>venture>>, there’s never been a better time to join us.

🔗 Find out more about the event and register by following the link in our bio.

📅 October 5, 2026 | 6:30 PM
📍 EPFL, MED Building (Lausanne)
🎟️ Free to attend

6 criteria. 200 spots. One form. Do you have what it takes?

Exciting changes are coming to the >>venture>> 2027 application process!

The application now begins with only a short online form. It opens October 1 and closes November 30. From every team that applies, 200 move forward to the full startup plan.

Six criteria decide who makes that cut: Innovation, Team, Technology & Product, Market, Sustainability & Impact, and Business.

We put the whole thing on one page so you can get a head start on your free application.

No fee. No 20-slide deck. Only one short form.

📄 Download our free one-pager and we will tell you the moment applications open: venture.ch

6 criteria. 200 spots. One form. Do you have what it takes?

Exciting changes are coming to the >>venture>> 2027 application process!

The application now begins with only a short online form. It opens October 1 and closes November 30. From every team that applies, 200 move forward to the full startup plan.

Six criteria decide who makes that cut: Innovation, Team, Technology & Product, Market, Sustainability & Impact, and Business.

We put the whole thing on one page so you can get a head start on your free application.

No fee. No 20-slide deck. Only one short form.

📄 Download our free one-pager and we will tell you the moment applications open: venture.ch

☀️ Summer Series | Pharma & Biotech

What if one of the biggest threats to modern medicine could be tackled with a vaccine?

For Ulrich Wuellner, Director External Innovation at @jnj, that's what makes a biotech startup compelling: identifying a problem that truly matters and showing how your solution could make a difference for patients.

In this year's Pharma & Biotech vertical, that ambition was everywhere. Baxiva, Isospec Analytics and Santella made it to the finals, tackling very different challenges across healthcare and life sciences.

But Baxiva's mission speaks directly to a growing global challenge: antimicrobial resistance.

The @ethzurich spin-off is developing vaccines against infections caused by Gram-negative bacteria, starting with extraintestinal pathogenic E. coli (ExPEC)—a major cause of urinary tract infections and a potentially life-threatening cause of sepsis. Despite the scale of the problem, there is currently no approved vaccine against ExPEC.

And as Bettina Ernst, CEO of PRECLIN Biosystems, reminds us, solving a problem this complex takes more than promising science. It takes a team with the expertise, passion and determination to bring it to the market.

That combination ultimately earned Baxiva the Advisory Board's selection as the Pharma & Biotech winner.

A bold scientific challenge. A significant unmet need. And a team determined to turn the two into a solution.

Congratulations to Baxiva, and to Isospec Analytics and Santella for making it to the finals. 👏

#venture #SwissStartups #Pharma #Biotech #Vaccines #Innovation

☀️ Summer Series | Pharma & Biotech

What if one of the biggest threats to modern medicine could be tackled with a vaccine?

For Ulrich Wuellner, Director External Innovation at @jnj, that's what makes a biotech startup compelling: identifying a problem that truly matters and showing how your solution could make a difference for patients.

In this year's Pharma & Biotech vertical, that ambition was everywhere. Baxiva, Isospec Analytics and Santella made it to the finals, tackling very different challenges across healthcare and life sciences.

But Baxiva's mission speaks directly to a growing global challenge: antimicrobial resistance.

The @ethzurich spin-off is developing vaccines against infections caused by Gram-negative bacteria, starting with extraintestinal pathogenic E. coli (ExPEC)—a major cause of urinary tract infections and a potentially life-threatening cause of sepsis. Despite the scale of the problem, there is currently no approved vaccine against ExPEC.

And as Bettina Ernst, CEO of PRECLIN Biosystems, reminds us, solving a problem this complex takes more than promising science. It takes a team with the expertise, passion and determination to bring it to the market.

That combination ultimately earned Baxiva the Advisory Board's selection as the Pharma & Biotech winner.

A bold scientific challenge. A significant unmet need. And a team determined to turn the two into a solution.

Congratulations to Baxiva, and to Isospec Analytics and Santella for making it to the finals. 👏

#venture #SwissStartups #Pharma #Biotech #Vaccines #Innovation

.pro-gallery-wix-wrapper {display: block !important;} .pro-gallery-wix-wrapper .gallery-item-container {opacity: 1 !important; display: block !important;}

Instagram

bottom of page